Exela Technologies, Inc. (NasdaqCM:XELA) Quant Signal Hits Key 36.00000 QI Value

Exela Technologies, Inc. (NasdaqCM:XELA) has a Q.i. Value of 36.00000. The purpose of the Q.i. Value is to help identify companies that are the most undervalued. Typically, the lower the value, the more undervalued the company tends to be. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. 

Many new traders will jump right into the market without any concrete plan. They may be highly optimistic, but will soon realize that it takes more than optimism to secure profits in the stock market. Successful traders are usually good at having a backup plan for every trade. This may seem unnecessary to some, but when the harsh reality of a losing trade comes into the picture, it can be hard to rebound after taking a big hit. Rushing into trades to try and cover recent losses may also leave the trader on the outside looking in. Taking a rationalized approach may help the trader ride out the bumpy patches when they inevitably come.

Checking in on some valuation rankings, Exela Technologies, Inc. (NasdaqCM:XELA) has a Value Composite score of 57. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 62.

Investors may be looking at all the different factors that come into play when searching for those next stocks to add to the portfolio. Maybe there are some names that have been on the radar, but the timing hasn’t been right to add them into the mix. As we get closer to the end of the year, investors may be looking back at individual stock performance over the past year. They may discover some great opportunities that weren’t available during the last review. Investors may also be keeping an eye on which sectors were the big winners during the latest earnings season. Branching out into new areas may help give the investor some alternative ideas for the next few quarters.

We can now take a quick look at some historical stock price index data. Exela Technologies, Inc. (NasdaqCM:XELA) presently has a 10 month price index of 0.84498. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period.

It can be very difficult to keep emotions on the sidelines when making important investing decisions. Even if all the number crunching is done unemotionally, there may be a tendency for those feelings of excitement or dread to creep in. Once the trade is made, it can be super difficult to make sane decisions when markets go haywire. Investors may have made some trades that didn’t pan out as planned, and they may have the itch to sell quickly in order to stop further losses. Selling a stock just because it is going down or buying a stock just because it is going up, might lead to portfolio struggles in the future. Obtaining a grasp on the bigger picture may help investors see through the cloudiness and make clearer decisions when the time comes.

Exela Technologies, Inc. (NasdaqCM:XELA) has a current ERP5 Rank of 19030. The ERP5 Rank may assist investors with spotting companies that are undervalued. This ranking uses four ratios. These ratios are Earnings Yield, ROIC, Price to Book, and 5 year average ROIC. When looking at the ERP5 ranking, it is generally considered the lower the value, the better.

Looking at some alternate time periods, the 12 month price index is 0.71534, the 24 month is 0.43289, and the 36 month is 0.43289. Narrowing in a bit closer, the 5 month price index is 0.60093, the 3 month is 0.97975, and the 1 month is currently 0.92806.

Watching some historical volatility numbers on shares of Exela Technologies, Inc. (NasdaqCM:XELA), we can see that the 12 month volatility is presently 46.422900. The 6 month volatility is 53.644900, and the 3 month is spotted at 46.725800.

Key Ratios

Turning to some key ratios, Exela Technologies, Inc. (NasdaqCM:XELA)’s Leverage Ratio was recently noted as 0.794526. This ratio is calculated by dividing total debt by total assets plus total assets previous year, divided by two. The leverage of a company is relative to the amount of debt on the balance sheet. This ratio is often viewed as one measure of the financial health of a firm.

Exela Technologies, Inc. (NasdaqCM:XELA) presently has a current ratio of 0.93. The current ratio, also known as the working capital ratio, is a liquidity ratio that displays the proportion of current assets of a business relative to the current liabilities. The ratio is simply calculated by dividing current liabilities by current assets. The ratio may be used to provide an idea of the ability of a certain company to pay back its liabilities with assets. Typically, the higher the current ratio the better, as the company may be more capable of paying back its obligations.

The price to book ratio or market to book ratio for Exela Technologies, Inc. (NasdaqCM:XELA) currently stands at -6.296998.  The ratio is calculated by dividing the stock price per share by the book value per share.  This ratio is used to determine how the market values the equity.  A ratio of under 1 typically indicates that the shares are undervalued.  A ratio over 1 indicates that the market is willing to pay more for the shares.  There are often many underlying factors that come into play with the Price to Book ratio so all additional metrics should be considered as well. 

Ever wonder how investors predict positive share price momentum?  The Cross SMA 50/200, also known as the “Golden Cross” is the fifty day moving average divided by the two hundred day moving average.  The SMA 50/200 for Exela Technologies, Inc. (NasdaqCM:XELA) is currently 0.79065.  If the Golden Cross is greater than 1, then the 50 day moving average is above the 200 day moving average – indicating a positive share price momentum.  If the Golden Cross is less than 1, then the 50 day moving average is below the 200 day moving average, indicating that the price might drop.

C Score (Montier)

The C-Score is a system developed by James Montier that helps determine whether a company is involved in falsifying their financial statements. The C-Score is calculated by a variety of items, including a growing difference in net income verse cash flow, increasing days outstanding, growing days sales of inventory, increasing assets to sales, declines in depreciation, and high total asset growth. The C-Score of Exela Technologies, Inc. (NasdaqCM:XELA) is 1.00000. The score ranges on a scale of -1 to 6. If the score is -1, then there is not enough information to determine the C-Score. If the number is at zero (0) then there is no evidence of fraudulent book cooking, whereas a number of 6 indicates a high likelihood of fraudulent activity. The C-Score assists investors in assessing the likelihood of a company cheating in the books.

Investors have many things to keep an eye on when trading the equity market. Riding through the ups and downs that come with market volatility may take some getting used to for beginners. Even if the investor does all the proper research and stock homework, things may not go as planned. One of the more important aspects of securing long-term success in the markets is learning how to execute a well-planned strategy all the way through to completion. Finding that right stocks to add to the portfolio may take some time and effort, but it can be accomplished. Deciding on the proper time to sell can be the trickiest part. Many investors will have the tendency to panic when markets are suffering. Although market panic may be fairly normal, it can have longer lasting adverse effects on the stock portfolio.